Design and evaluation of pyrimidine derivatives as potent inhibitors of ABCG2, a breast cancer resistance protein.
3 Biotech
; 12(9): 182, 2022 Sep.
Article
in En
| MEDLINE
| ID: mdl-35875174
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
3 Biotech
Year:
2022
Document type:
Article
Country of publication:
Germany